Insights into cholesterol efflux in vascular endothelial cells

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 7, Issue 2, 2007, Pages 127-134

  Xie, Xuefen ^a   Zhu, Yi ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

ABCA1; Caveolae; Cholesterol; ECs; LXR

Indexed keywords

ABC TRANSPORTER A1; ALBUMIN; APOLIPOPROTEIN A1; CAVEOLIN 1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LIPOSOME; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLSERINE; RETINOID X RECEPTOR; SCAVENGER RECEPTOR BI;

ATHEROGENESIS; CAVEOLA; CELL STRUCTURE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DIFFUSION; ENDOTHELIUM CELL; GENE MUTATION; HUMAN; LAMINAR FLOW; LIPID METABOLISM; NONHUMAN; PATHOGENESIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TANGIER DISEASE; TRANSPORT KINETICS; VASCULAR ENDOTHELIUM;

EID: 34347405985     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152907780830923     Document Type: Review

References (113)

1. Rothblat, G. H.; de, l. L. M.; Favari, E.; Yancey, P. G.; Kellner-Weibel, G. Cellular cholesterol flux studies: methodological considerations. Atherosc., 2002, 163, 1-8.
2. Fielding, C. J.; Fielding, P. E. Intracellular cholesterol transport. J. Lipid Res., 1997, 38, 1503-1521.
3. Johnson, W. J.; Mahlberg, F. H.; Rothblat, G. H.; Phillips, M. C. Cholesterol transport between cells and high-density lipoproteins. Biochim. Biophys. Acta, 1991, 1085, 273-298.
4. Fielding, C. J.; Fielding, P. E. Cellular cholesterol efflux. Biochim. Biophys. Acta, 2001, 1533, 175-189.
5. Krieger, M.; Herz, J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem., 1994, 63, 601-637.
6. Matsumoto, K.; Hirano, K.; Nozaki, S.; Takamoto, A.; Nishida, M.; Nakagawa-Toyama, Y.; Janabi, M. Y.; Ohya, T.; Yamashita, S.; Matsuzawa, Y. Expression of macrophage (Mphi) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-gamma, which regulates gain of Mphi-like phenotype in vitro, and its implication in atherogenesis. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 1027-1032.
7. Fielding, P. E.; Fielding, C. J. Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochem., 1995, 34, 14288-14292.
8. Lin, T.; Zeng, L.; Liu, Y.; DeFea, K.; Schwartz, M. A.; Chien, S.; Shyy, J. Y. Rho-ROCK-LIMK-cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins. Circ. Res., 2003, 92, 1296-1304.
9. Yeh, M.; Cole, A. L.; Choi, J.; Liu, Y.; Tulchinsky, D.; Qiao, J. H.; Fishbein, M. C.; Dooley, A. N.; Hovnanian, T.; Mouilleseaux, K.; Vora, D. K.; Yang, W. P.; Gargalovic, P.; Kirchgessner, T.; Shyy, J. Y.; Berliner, J. A. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products. Circ. Res., 2004, 95, 780-788.
10. Fielding, C. J.; Fielding, P. E. Caveolae and intracellular trafficking of cholesterol. Adv. Drug Deliv. Rev., 2001, 49, 251-264.
11. Ji, Y.; Jian, B.; Wang, N.; Sun, Y.; Moya, M. L.; Phillips, M. C.; Rothblat, G. H.; Swaney, J. B.; Tall, A. R. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem., 1997, 272, 20982-20985.
12. Kellner-Weibel, G.; de, L. L.M.; Connelly, M. A.; Stoudt, G.; Christian, A. E.; Haynes, M. P.; Williams, D. L.; Rothblat, G. H. Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution. Biochemisty, 2000, 39, 221-229.
13. Mendez, A. J.; Lin, G.; Wade, D. P.; Lawn, R. M.; Oram, J. F. Membrane lipid domains distinct from cholesterol/sphingomyelinrich rafts are involved in the ABCA1-mediated lipid secretory pathway. J. Biol. Chem., 2001, 276, 3158-3166.
14. Schmitz, G.; Langmann, T. Structure, function and regulation of the ABC1 gene product. Curr. Opin. Lipidol., 2001, 12, 129-140.
15. Oram, J. F. Tangier disease and ABCA1. Biochim. Biophys. Acta. 2000, 1529, 321-330.
16. Rothblat, G. H.; Phillips, M. C. Mechanism of cholesterol efflux from cells. Effects of acceptor structure and concentration. J. Biol. Chem., 1982, 257, 4775-4782.
17. Phillips, M. C.; Johnson, W. J.; Rothblat, G. H. Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta, 1987, 906, 223-276.
18. Phillips, M. C.; Gillotte, K. L.; Haynes, M. P.; Johnson, W. J.; Lund-Katz, S.; Rothblat, G. H. Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes. Atheroscle., 1998, 137 Suppl, S13-S17.
19. Pohl, P.; Saparov, S. M.; Antonenko, Y. N. The size of the un-stirred layer as a function of the solute diffusion coefficient. Biophys. J., 1998, 75, 1403-1409.
20. Rothblat, G. H.; de, I. L.M.; Atger, V.; Kellner-Weibel, G.; Williams, D. L.; Phillips, M. C. Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res., 1999, 40, 781-796.
21. Yuan, Y.; Verna, L. K.; Wang, N. P.; Liao, H. L.; Ma, K. S.; Wang, Y.; Zhu, Y.; Stemerman, M. B. Cholesterol enrichment upregulates intercellular adhesion molecule-1 in human vascular endothelial cells. Biochim. Biophys. Acta. 2001, 1534, 139-148.
22. Fielding, C. J.; Moser, K. Evidence for the separation of albumin- and apo A-I-dependent mechanisms of cholesterol efflux from cultured fibroblasts into human plasma. J. Biol. Chem., 1982, 257, 10955-10960.
23. Zhao, Y.; Marcel, Y. L. Serum albumin is a significant intermediate in cholesterol transfer between cells and lipoproteins. Biochemistry, 1996, 35, 7174-7180.
24. Zhu, Y.; Liao, H.; Xie, X.; Yuan, Y.; Lee, T. S.; Wang, N.; Wang, X.; Shyy, J. Y.; Stemerman, M. B. Oxidized LDL downregulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR). Cardiovasc. Res., 2005, 68, 425-432.
25. Pittman, R. C.; Knecht, T. P.; Rosenbaum, M. S.; Taylor, C. A.; Jr. A nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. J. Biol. Chem., 1987, 262, 2443-2450.
26. Gu, X.; Trigatti, B.; Xu, S.; Acton, S.; Babitt, J.; Krieger, M. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J. Biol. Chem., 1998, 273, 26338-26348.
27. Connelly, M. A.; Klein, S. M.; Azhar, S.; Abumrad, N. A.; Williams, D. L. Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J. Biol. Chem., 1999, 274, 41-47.
28. Stangl, H.; Cao, G.; Wyne, K. L.; Hobbs, H. H. Scavenger receptor, class B, type I-dependent stimulation of cholesterol esterification by high density lipoproteins, low density lipoproteins, and nonlipoprotein cholesterol. J. Biol. Chem., 1998, 273, 31002-31008.
29. Swarnakar, S.; Temel, R. E.; Connelly, M. A.; Azhar, S.; Williams, D. L. Scavenger receptor class B, type I, mediates selective uptake of low density lipoprotein cholesteryl ester. J. Biol. Chem., 1999, 274, 29733-29739.
30. Stangl, H.; Hyatt, M.; Hobbs, H. H. Transport of lipids from high and low density lipoproteins via scavenger receptor-BI. J. Biol. Chem., 1999, 274, 32692-32698.
31. Yancey, P. G.; de, I. L.M.; Swarnakar, S.; Monzo, P.; Klein, S. M.; Connelly, M. A.; Johnson, W. J.; Williams, D. L.; Rothblat, G. H. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J. Biol. Chem., 2000, 275, 36596-36604.
32. de, L. L.M.; Connelly, M. A.; Drazul, D.; Klein, S. M.; Favari, E.; Yancey, P. G.; Williams, D. L.; Rothblat, G. H. Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL. J. Lipid Res., 2001, 42, 1969-1978.
33. Lund-Katz, S.; Liu, L.; Thuahnai, S. T.; Phillips, M. C. High density lipoprotein structure. Front Biosci., 2003, 8, d1044-d1054.
34. Thuahnai, S. T.; Lund-Katz, S.; Anantharamaiah, G. M.; Williams, D. L.; Phillips, M. C. A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins. J. Lipid Res., 2003, 44, 1132-1142.
35. Liadaki, K. N.; Liu, T.; Xu, S.; Ishida, B. Y.; Duchateaux, P. N.; Krieger, J. P.; Kane, J.; Krieger, M.; Zannis, V. I. Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL receptor scavenger receptor class B type I. Effect of lipid association and APOA-I mutations on receptor binding. J. Biol. Chem., 2000, 275, 21262-21271.
36. de Beer, M. C.; Durbin, D. M.; Cai, L.; Jonas, A.; de Beer, F. C.; van der Westhuyzen, D. R. Apolipoprotein A-I conformation markedly influences HDL interaction with scavenger receptor BI. J. Lipid Res., 2001, 42, 309-313.
37. Williams, D. L.; de, L. L.M.; Thuahnai, S. T.; Lund-Katz, S.; Connelly, M. A.; Azhar, S.; Anantharamaiah, G. M.; Phillips, M. C. Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class A amphipathic alpha-helix as a recognition motif. J. Biol. Chem., 2000, 275, 18897-18904.
38. Ji, Y.; Jian, B.; Wang, N.; Sun, Y.; Moya, M. L.; Phillips, M. C.; Rothblat, G. H.; Swaney, J. B.; Tall, A. R. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem., 1997, 272, 20982-20985.
39. Fournier, N.; de la Llera, M. M.; Burkey, B. F, Swaney, J. B.; Paterniti, J. Jr.; Moatti, N.; Atger, V.; Rothblat, G. H. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats. J. Lipid Res., 1996, 37, 1704-1711.
40. Fournier, N.; Paul, J. L.; Atger, V.; Cogny, A.; Soni, T.; de, l. L.M.; Rothblat, G.; Moatti, N. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler. Thromb. Vasc. Biol., 1997, 17, 2685-2691.
41. O'Connell, B. J.; Denis, M.; Genest, J. Cellular physiology of cholesterol efflux in vascular endothelial cells. Circulation, 2004, 110, 2881-2888.
42. Dean, M.; Hamon, Y.; Chimini, G. The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res., 2001, 42, 1007-1017.
43. Langmann, T.; Klucken, J.; Reil, M.; Liebisch, G.; Luciani, M. F.; Chimini, G.; Kaminski, W. E.; Schmitz, G. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun., 1999, 257, 29-33.
44. Bortnick, A. E.; Rothblat, G. H.; Stoudt, G.; Hoppe, K. L.; Royer, L. J.; McNeish, J.; Francone, O. L. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J. Biol. Chem., 2000, 275, 28634-28640.
45. Denis, M.; Bissonnette, R.; Haidar, B.; Krimbou, L.; Bouvier, M.; Genest, J. Expression, regulation, and activity of ABCA1 in human cell lines. Mol. Genet. Metab., 2003, 78, 265-274.
46. Lawn, R. M.; Wade, D. P.; Couse, T. L.; Wilcox, J. N. Localization of human ATP-binding cassette transporter 1 (ABC1) in normal and atherosclerotic tissues. Arterioscler. Thromb. Vasc. Biol., 2001, 21, 378-385.
47. Brooks-Wilson, A.; Marcil, M.; Clee, S. M.; Zhang, L. H.; Roomp, K.; van, D. M.; Yu, L.; Brewer, C.; Collins, J. A.; Molhuizen, H. O.; Loubser, O.; Ouelette, B. F.; Fichter, K.; shbourne-Excoffon, K. J.; Sensen, C. W.; Scherer, S.; Mott, S.; Denis, M.; Martindale, D.; Frohlich, J.; Morgan, K.; Koop, B.; Pimstone, S.; Kastelein, J. J.; Genest, J. Jr.; Hayden, M. R. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet., 1999, 22, 336-345.
48. Bodzioch, M.; Orso, E.; Klucken, J.; Langmann, T.; Bottcher, A.; Diederich, W.; Drobnik, W.; Barlage, S.; Buchler, C.; Porsch-Ozcurumez, M.; Kaminski, W. E.; Hahmann, H. W.; Oette, K.; Rothe, G.; Aslanidis, C.; Lackner, K. J.; Schmitz, G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet., 1999, 22, 347-351.
49. Rust, S.; Rosier, M.; Funke, H.; Real, J.; Amoura, Z.; Piette, J. C.; Deleuze, J. F.; Brewer, H. B.; Duverger, N.; Denefle, P.; Assmann, G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet., 1999, 22, 352-355.
50. Lawn, R. M.; Wade, D. P.; Garvin, M. R.; Wang, X.; Schwartz, K.; Porter, J. G.; Seilhamer, J. J.; Vaughan, A. M.; Oram, J. F. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest., 1999, 104, R25-R31.
51. Tall, A. R.; Wang, N. Tangier disease as a test of the reverse cholesterol transport hypothesis. J. Clin. Invest., 2000, 106, 1205-1207.
52. Joyce, C. W.; Amar, M. J.; Lambert, G.; Vaisman, B. L.; Paigen, B.; Najib-Fruchart, J.; Hoyt, R. F. Jr.; Neufeld, E. D.; Remaley, A. T.; Fredrickson, D. S.; Brewer, H. B. Jr.; Santamarina-Fojo, S. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc. Natl. Acad. Sci. USA, 2002, 99, 407-412.
53. Liao, H.; Langmann, T.; Schmitz, G.; Zhu, Y. Native LDL upregulation of ATP-binding cassette transporter-1 in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol., 2002, 22, 127-132.
54. Panzenboeck, U.; Balazs, Z.; Sovic, A.; Hrzenjak, A.; Levak-Frank, S.; Wintersperger, A.; Malle, E.; Sattler, W. ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells. J. Biol. Chem., 2002, 277, 42781-42789.
55. Hoekstra, M.; Kruijt, J. K.; Van, E. M.; Van Berkel, T. J. Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells. J. Biol. Chem., 2003, 278, 25448-25453.
56. Fielding, P. E.; Nagao, K.; Hakamata, H.; Chimini, G.; Fielding, C. J. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1. Biochemistry, 2000, 39, 14113-14120.
57. Francis, G. A.; Knopp, R. H.; Oram, J. F. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J. Clin. Invest., 1995, 96, 78-87.
58. Segrest, J. P.; Jones, M. K.; De, L. H.; Brouillette, C. G.; Venkatachalapathi, Y. V.; Anantharamaiah, G. M. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res., 1992, 33, 141-166.
59. Gillotte, K. L.; Zaiou, M.; Lund-Katz, S.; Anantharamaiah, G. M.; Holvoet, P.; Dhoest, A.; Palgunachari, M. N.; Segrest, J. P.; Weisgraber, K. H.; Rothblat, G. H.; Phillips, M. C. Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid. J. Biol. Chem., 1999, 274, 2021-2028.
60. Chroni, A.; Liu, T.; Gorshkova, I.; Kan, H. Y.; Uehara, Y.; Von, E. A.; Zannis, V. I. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo. J. Biol. Chem., 2003, 278, 6719-6730.
61. Fitzgerald, M. L.; Morris, A. L.; Rhee, J. S.; Andersson, L. P.; Mendez, A. J.; Freeman, M. W. Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I. J. Biol. Chem., 2002, 277, 33178-33187.
62. Chambenoit, O.; Hamon, Y.; Marguet, D.; Rigneault, H.; Rosseneu, M.; Chimini, G. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter. J. Biol. Chem., 2001, 276, 9955-9960.
63. Wang, N.; Silver, D. L.; Costet, P.; Tall, A. R. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem., 2000, 275, 33053-33058.
64. Vaughan, A. M.; Oram, J. F. ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions. J. Lipid Res., 2003, 44, 1373-1380.
65. Cavelier, C.; Rohrer, L.; von, E. A. ATP-Binding cassette transporter A1 modulates apolipoprotein A-I transcytosis through aortic endothelial cells. Circ. Res., 2006, 99, 1060-1066.
66. Hamon, Y.; Broccardo, C.; Chambenoit, O.; Luciani, M. F.; Toti, F.; Chaslin, S.; Freyssinet, J. M.; Devaux, P. F.; McNeish, J.; Marguet, D.; Chimini, G. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat. Cell Biol., 2000, 2, 399-406.
67. Wang, N.; Lan, D.; Gerbod-Giannone, M.; Linsel-Nitschke, P.; Jehle, A. W.; Chen, W.; Martinez, L. O.; Tall, A. R. ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux. J. Biol. Chem., 2003, 278, 42906-42912.
68. Kiss, R. S.; Maric, J.; Marcel, Y. L. Lipid efflux in human and mouse macrophagic cells: evidence for differential regulation of phospholipid and cholesterol efflux. J. Lipid Res., 2005, 46, 1877-1887.
69. Zheng, H.; Kiss, R. S.; Franklin, V.; Wang, M. D.; Haidar, B.; Marcel, Y. L. ApoA-I lipidation in primary mouse hepatocytes. Separate controls for phospholipid and cholesterol transfers. J. Biol. Chem., 2005, 280, 21612-21621.
70. Smith, J. D.; Le, G. W.; Settle, M.; Brubaker, G.; Waelde, C.; Horwitz, A.; Oda, M. N. ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I. J. Lipid Res., 2004, 45, 635-644.
71. Gillotte, K. L.; Davidson, W. S.; Lund-Katz, S.; Rothblat, G. H.; Phillips, M. C. Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization. J. Lipid Res., 1998, 39, 1918-1928.
72. Repa, J. J.; Mangelsdorf, D. J. Nuclear receptor regulation of cholesterol and bile acid metabolism. Curr. Opin. Biotechnol. 1999, 10, 557-563.
73. Costet, P.; Luo, Y.; Wang, N.; Tall, A. R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem., 2000, 275, 28240-28245.
74. Schwartz, K.; Lawn, R. M.; Wade, D. P. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem. Biophys. Res. Commun., 2000, 274, 794-802.
75. Reiss, A. B.; Martin, K. O.; Javitt, N. B.; Martin, D. W.; Grossi, E. A.; Galloway, A. C. Sterol 27-hydroxylase: high levels of activity in vascular endothelium. J. Lipid Res., 1994, 35, 1026-1030.
76. Fu, X.; Menke, J. G.; Chen, Y.; Zhou, G.; MacNaul, K. L.; Wright, S. D.; Sparrow, C. P.; Lund, E. G. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem., 2001, 276, 38378-38387.
77. Babiker, A.; Andersson, O.; Lund, E.; Xiu, R. J.; Deeb, S.; Reshef, A.; Leitersdorf, E.; Diczfalusy, U.; Bjorkhem, I. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J. Biol. Chem., 1997, 272, 26253-26261.
78. Zhu, Y.; Liao, H. L.; Wang, N.; Yuan, Y.; Ma, K. S.; Verna, L.; Stemerman, M. B. Lipoprotein promotes caveolin-1 and Ras translocation to caveolae: role of cholesterol in endothelial signaling. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 2465-2470.
79. Pritchard, K. A. Jr.; Schwarz, S. M.; Medow, M. S.; Stemerman, M. B. Effect of low-density lipoprotein on endothelial cell membrane fluidity and mononuclear cell attachment. Am. J. Physiol., 1991, 260, C43-C49.
80. Chawla, A.; Boisvert, W. A.; Lee, C. H.; Laffitte, B. A.; Barak, Y.; Joseph, S. B.; Liao, D.; Nagy, L.; Edwards, P. A.; Curtiss, L. K.; Evans, R. M.; Tontonoz, P. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell, 2001, 7, 161-171.
81. Chinetti, G.; Lestavel, S.; Bocher, V.; Remaley, A. T.; Neve, B.; Torra, I. P.; Teissier, E.; Minnich, A.; Jaye, M.; Duverger, N.; Brewer, H. B.; Fruchart, J. C.; Clavey, V.; Staels, B. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat. Med., 2001, 7, 53-58.
82. Schmitz, G.; Langmann, T. Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim. Biophys. Acta, 2005, 1735, 1-19.
83. Sporstol, M.; Tapia, G.; Malerod, L.; Mousavi, S. A.; Berg, T. Pregnane X receptor-agonists down-regulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I. Biochem. Biophys. Res. Commun., 2005, 331, 1533-1541.
84. Gan, X.; Kaplan, R.; Menke, J. G.; MacNaul, K.; Chen, Y.; Sparrow, C. P.; Zhou, G.; Wright, S. D.; Cai, T. Q. Dual mechanisms of ABCA1 regulation by geranylgeranyl pyrophosphate. J. Biol. Chem., 2001, 276, 48702-48708.
85. Porsch-Ozcurumez, M.; Langmann, T.; Heimerl, S.; Borsukova, H.; Kaminski, W. E.; Drobnik, W.; Honer, C.; Schumacher, C.; Schmitz, G. The zinc finger protein 202 (ZNF202) is a transcriptional repressor of ATP binding cassette transporter A1 (ABCA1) and ABCG1 gene expression and a modulator of cellular lipid efflux. J. Biol. Chem., 2001, 276, 12427-12433.
86. Santamarina-Fojo, S.; Peterson, K.; Knapper, C.; Qiu, Y.,Freeman, L.; Cheng, J. F.; Osorio, J.; Remaley, A.; Yang, X. P.; Haudenschild, C.; Prades, C.; Chimini, G.; Blackmon, E.; Francois, T.; Duverger, N.; Rubin, E. M.; Rosier, M.; Denefle, P.; Fredrickson, D. S.; Brewer, H. B. Jr. Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc. Natl. Acad. Sci.; USA, 2000, 97, 7987-7992.
87. Haidar, B.; Denis, M.; Krimbou, L.; Marcil, M.; Genest, J. Jr. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J. Lipid Res., 2002, 43, 2087-2094.
88. Oram, J. F.; Lawn, R. M.; Garvin, M. R.; Wade, D. P. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem., 2000, 275, 34508-34511.
89. Zeng, L.; Liao, H.; Liu, Y.; Lee, T. S.; Zhu, M.,Wang, X.; Stemerman, M. B.; Zhu, Y.; Shyy, J. Y. Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism. J. Biol. Chem., 2004, 279, 48801-48807.
90. Lusis, A. J. Atherosclerosis. Nature, 2000, 407, 233-241.
91. Panousis, C. G.; Zuckerman, S. H. Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 1565-1571.
92. Panousis, C. G.; Evans, G.; Zuckerman, S. H. TGF-beta increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: opposing the effects of IFN-gamma. J. Lipid Res., 2001, 42, 856-863.
93. Stolz, D. B.; Jacobson, B. S. Macro- and microvascular endothelial cells in vitro: maintenance of biochemical heterogeneity despite loss of ultrastructural characteristics. In Vitro Cell Dev. Biol., 1991, 27A, 169-182.
94. Schnitzer, J. E.; Oh, P.; Jacobson, B. S.; Dvorak, A. M. Caveolae from luminal plasmalemma of rat lung endothelium: microdomains enriched in caveolin, Ca(2+)-ATPase, and inositol trisphosphate receptor. Proc. Natl. Acad. Sci.; USA, 1995, 92, 1759-1763.
95. Peters, K. R.; Carley, W. W.; Palade, G. E. Endothelial plasmalemmal vesicles have a characteristic striped bipolar surface structure. J. Cell Biol., 1985, 101, 2233-2238.
96. Rothberg, K. G.; Heuser, J. E.; Donzell, W. C.; Ying, Y. S.; Glenney, J. R.; Anderson, R. G. Caveolin, a protein component of caveolae membrane coats. Cell, 1992, 68, 673-682.
97. Ilangumaran, S.; Hoessli, D. C. Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem. J., 1998, 335, 433-440.
98. Smart, E. J.; Ying, Y. S.; Conrad, P. A.; Anderson, R. G. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J. Cell Biol., 1994, 127, 1185-1197.
99. Chang, W. J.; Rothberg, K. G.; Kamen, B. A.; Anderson, R. G. Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folate. J. Cell Bio., 1992, 118, 63-69.
100. Hailstones, D.; Sleer, L. S.; Parton, R. G.; Stanley, K. K. Regulation of caveolin and caveolae by cholesterol in MDCK cells. J. Lipid Res., 1998, 39, 369-379.
101. Scherer, P. E.; Tang, Z.; Chun, M.; Sargiacomo, M.; Lodish, H. F.; Lisanti, M. P. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J. Biol. Chem., 1995, 270, 16395-16401.
102. Bist, A.; Fielding, P. E.; Fielding, C. J. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc. Natl. Acad. Sci. USA, 1997, 94, 10693-10698.
103. Frank, P. G.; Galbiati, F.; Volonte, D.; Razani, B.; Cohen, D. E.; Marcel, Y. L.; Lisanti, M. P. Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins. Am. J. Physiol. Cell Physiol., 2001, 280, C1204-C1214.
104. Pol, A.; Luetterforst, R.; Lindsay, M.; Heino, S.; Ikonen, E.; Parton, R. G. A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance. J. Cell Biol., 2001, 152, 1057-1070.
105. Arakawa, R.; be-Dohmae, S.; Asai, M.; Ito, J. I.; Yokoyama, S. Involvement of caveolin-1 in cholesterol enrichment of high density lipoprotein during its assembly by apolipoprotein and THP-1 cells. J. Lipid Res., 2000, 41, 1952-1962.
106. Graf, G. A.; Connell, P. M.; van der Westhuyzen, D. R.; Smart, E. J. The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into caveolae. J. Biol. Chem., 1999, 274, 12043-12048.
107. Babitt, J.; Trigatti, B.; Rigotti, A.; Smart, E. J.; Anderson, R. G.; Xu, S.; Krieger, M. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J. Biol. Chem., 1997, 272, 13242-13249.
108. Uittenbogaard, A.; Everson, W. V.; Matveev, S. V.; Smart, E. J. Cholesteryl ester is transported from caveolae to internal membranes as part of a caveolin-annexin II lipid-protein complex. J. Biol. Chem., 2002, 277, 4925-4931.
109. Briand, O.; Lestavel, S.; Pilon, A.; Torpier, G.; Fruchart, J. C.; Clavey, V. SR-BI does not require raft/caveola localisation for cholesteryl ester selective uptake in the human adrenal cell line NCI-H295R. Biochim. Biophys. Acta. 2003, 1631, 42-50.
110. Wang, L.; Connelly, M. A.; Ostermeyer, A. G.; Chen, H. H.; Williams, D. L.; Brown, D. A. Caveolin-1 does not affect SR-BI-mediated cholesterol efflux or selective uptake of cholesteryl ester in two cell lines. J. Lipid Res., 2003, 44, 807-815.
111. Matveev, S.; Uittenbogaard, A.; van Der, W. D.; Smart, E. J. Caveolin-1 negatively regulates SR-BI mediated selective uptake of high-density lipoprotein-derived cholesteryl ester. Eur. J. Biochem., 2001, 268, 5609-5616.
112. Chao, W. T.; Tsai, S. H.; Lin, Y. C.; Lin, W. W.; Yang, V. C. Cellular localization and interaction of ABCA1 and caveolin-1 in aortic endothelial cells after HDL incubation. Biochem. Biophys. Res. Commun., 2005, 332, 743-749.
113. Landry, Y. D.; Denis, M.; Nandi, S.; Bell, S.; Vaughan, A. M.; Zha, X. ABCA1 expression disrupts raft membrane microdomains through its ATPase-related functions. J. Biol. Chem., 2006, 281, 36091-36101.